Alianza Multidisciplinar Para La Investigacion De Los Tumores Genitourinarios Guard

The sponsor’s clinical research activity is centered on metastatic hormone-sensitive prostate cancer, with a focus on disease control in patients whose PSA response remains insufficient after initial treatment. This area reflects a strong interest in treatment strategies for advanced genitourinary cancer.

• Metastatic hormone-sensitive prostate cancer
• PSA response assessment
• Advanced prostate cancer management

Research activity in this field is linked to collaborative oncology care across multiple sites in Spain and other participating countries, supporting clinical work in urologic oncology.